arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ARTIVION, INC.

AORT
$27.16 ▲ +0.61 (+2.30%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome

Analytical Summary

ARTIVION, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.2B
Dividend Yield
Revenue Growth 13.6%
Op. Margin 7.6%
ROIC 3.4%
FCF / Share $0.02
Trailing P/E 123.5x
Price / Book 2.8x
FCF Yield 0.1%
Debt / Equity 0.48
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$441.33M
↑ +13.6%
Net Income Profit after all expenses
$9.77M
↑ +173.1%
Operating Margin Operating profit as % of sales
7.6%
↓ -23.6% 51th
FCF / Share Free cash flow per share
$0.02
↓ -93.0%
Long-Term Debt Long-term obligations
$215.11M
↓ -31.6%

Health Breakdown

Profitability
39
Returns
48
Financial Health
52
Cash Quality
25

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters